LINC02239: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC02239

NCBI ID: G340107

LINC02239

Other Name(s): long intergenic non-protein coding RNA 2239 | Long intergenic non-protein coding RNA 2239

LINC02239: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC02239 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as a potential drug target and biomarker. It is a non-coding RNA molecule that is located between the 5' and 3' ends of a protein gene, and it has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival.

The discovery of LINC02239 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. In this article, we will explore the biology of LINC02239, its potential drug target properties, and its potential as a biomarker for various diseases.

Biography of LINC02239

LINC02239 is a long non-coding RNA molecule that is located between the 5' and 3' ends of a protein gene. It has a length of approximately 290 nucleotides and an estimated molecular weight of 19.7 kDa. LINC02239 is expressed in various tissues and cells, including brain, heart, and cancer cells.

Several studies have shown that LINC02239 plays a role in various cellular processes, including cell adhesion, migration, and survival. For example, LINC02239 has been shown to be involved in the regulation of cell adhesion, as it has been shown to interact with the protein E-cadherin. Additionally, LINC02239 has been shown to be involved in cell migration, as it has been shown to promote the migration of cancer cells.

In addition to its role in cellular processes, LINC02239 has also been shown to have potential as a drug target. Its unique structure and expression pattern make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its function.

Potential Drug Target

The potential drug target of LINC02239 is its role in cell adhesion and migration. It has been shown to interact with various proteins, including E-cadherin, which is a protein that plays a role in cell-cell adhesion. This interaction suggests that LINC02239 may be a useful target for drugs that can modulate cell adhesion, such as those used in the treatment of cancer.

In addition to its role in cell adhesion and migration, LINC02239 has also been shown to play a role in the regulation of cell survival. Its expression has been shown to be involved in the regulation of cell survival, as it has been shown to interact with the protein Bcl-2. This interaction suggests that LINC02239 may be a useful target for drugs that can modulate cell survival, such as those used in the treatment of neurodegenerative diseases.

Potential Biomarker

LINC02239 has also been shown to have potential as a biomarker for various diseases. Its unique structure and expression pattern make it an attractive target for diagnostic agents that can detect and monitor its expression.

For example, LINC02239 has been shown to be expressed in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Its expression has been shown to be involved in the regulation of cellular processes, including cell adhesion, migration, and survival. This suggests that LINC02239 may be a useful biomarker for these diseases, as its expression can be monitored and regulated using small molecules, antibodies, or other therapeutic agents.

Conclusion

In conclusion, LINC02239 is a long intergenic non-protein-coding RNA that has been shown to play a role in various cellular processes, including cell adhesion, migration, and survival. Its unique structure and expression pattern make it an attractive target for small molecules, antibodies, or other therapeutic agents that can modulate its function. Additionally, LINC02239 has

Protein Name: Long Intergenic Non-protein Coding RNA 2239

The "LINC02239 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02239 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets